What is the recommended initial management for fibromyalgia, including non‑pharmacologic measures and first‑line pharmacologic options?

Initial Management of Fibromyalgia

Start all patients with fibromyalgia with patient education and aerobic/strengthening exercise as the only intervention with strong evidence for benefit, then add pharmacotherapy only if non-pharmacological measures prove insufficient after an adequate trial. 1

Graduated Treatment Algorithm

Stage 1: Initial Management (All Patients)

Begin with non-pharmacological therapies exclusively:

• Patient education about fibromyalgia as a chronic pain condition involving abnormal pain processing
• Aerobic and strengthening exercise - this is the ONLY intervention with "strong for" recommendation based on meta-analyses (100% expert agreement) 1
• Provide written information materials about the condition 1

Key point: Exercise is the cornerstone of initial management and has the strongest evidence base of any fibromyalgia treatment. The effect size for most other treatments is relatively modest by comparison 1.

Stage 2: If Insufficient Response to Exercise Alone

Add additional non-pharmacological interventions based on specific symptoms (all have "weak for" recommendations):

• Cognitive behavioral therapy - particularly for patients with mood disorders or unhelpful coping strategies 1
• Multicomponent therapies (93% agreement) 1
• Physical therapies: acupuncture or hydrotherapy (93% agreement) 1
• Meditative movement therapies: qigong, yoga, tai chi, or mindfulness-based stress reduction (71-73% agreement) 1

Stage 3: Pharmacological Options (Only After Non-Pharmacological Trial)

Introduce medications only for severe pain or sleep disturbance that has not responded to non-pharmacological measures 1. All pharmacological options carry "weak for" recommendations:

First-line pharmacological choices (100% expert agreement):

• Amitriptyline (low dose) 1
• Duloxetine or milnacipran 1
• Tramadol 1

Second-line options:

• Pregabalin (94% agreement) 1
• Cyclobenzaprine (75% agreement) - note that 85% of patients experience side effects and only 71% complete studies 1

Critical Implementation Points

Tailor treatment to individual symptom profiles:

• Severe pain → consider duloxetine, milnacipran, or tramadol
• Sleep disturbance → consider amitriptyline or cyclobenzaprine
• Comorbid depression/anxiety → prioritize duloxetine or amitriptyline 1

What NOT to use:

• NSAIDs have not demonstrated benefits for fibromyalgia 2
• Opioids have significant limitations and should be avoided 2

Common Pitfalls to Avoid

1. Starting with medications first - The evidence clearly supports non-pharmacological approaches as initial management, with exercise being the only strong recommendation 1

2. Expecting large treatment effects - Be transparent with patients that effect sizes for most treatments are relatively modest 1

3. Failing to provide adequate patient education - Establishing the diagnosis and providing education can reassure patients and decrease unnecessary testing 2

4. Not allowing sufficient time for exercise programs - Physical therapy should involve individualized graded physical exercise 1

Shared Decision-Making

Management should balance benefit and risk through shared decision-making with patients, considering pain intensity, function, associated features, fatigue, sleep disturbance, patient preferences, and comorbidities 1. The multidisciplinary approach combining non-pharmacological and pharmacological modalities aims to improve health-related quality of life 1.